Clinigen Group agrees new credit facility with RBS

4th Apr 2014 07:47

Pharmaceutical company Clinigen Group has agreed a new four-year 35m pound multi-currency revolving credit facility with Royal Bank of Scotland (RBS).Under the agreement, Clinigen can request an additional £15m on the same terms.The facility replaces the existing £20m facility with RBS and is secured on the tangible and intangible assets of the group. Clinigen's Chief Financial Officer, Robin Sibson, said: "This significantly increased facility will provide us with the flexibility to continue to deliver our strategy of adding to our SP product portfolio whilst we continue to drive the business forward through organic growth." RD